New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 10, 2024 - The FDA approved a new oral tablet formulation of Eli Lilly’s Retevmo (selpercatinib).
Download PDF
Return to publications
